The integrin VLA-2 mediates cell adhesion to collagen and laminin and also functions as a virus receptor, mediating cell surface attachment and infection by a human pathogen, echovirus 1. To determine whether extracellular matrix proteins and virus interact with VLA-2 in the same manner, we carried out a detailed comparison of these two functions and found that they differed markedly in six different respects. In contrast to the ECM/VLA-2 interaction, echovirus 1 binding did not discriminate between functional forms of VLA-2, showed a different pattern of inhibition by anti-,81 and -a2 antibodies, was not stimulated by phorbol esters, was not activated by (1 antibodies that stimulate ECM binding, was not inhibited by any particular divalent cation, and most notably was not inhibited by EDTA. These striking differences were found both with intact cells expressing VLA-2 and with solubilized VLA-2, suggesting that VLA-2 interacts with these different ligands by markedly different mechanisms, and probably at different functional sites. In addition, alterations in the a2 cytoplasmic domain that had marked effects on cellular responses to collagen and laminin had no effect on virus internalization and cell killing. Thus VLA-2-mediated events that occur after receptor occupancy by extracellular matrix proteins also appear to be distinct from those that occur after receptor interaction with virus. (J. Clin. Invest. 1993. 92:232-239.)
Introduction
The integrin family ofcell surface molecules is composed of 14 a subunits and 8/ subunits that pair noncovalently to form 20 different heterodimers, each with distinct ligand binding capabilities. Ligands for integrins include extracellular matrix components, members of the immunoglobulin family, and blood clotting and complement proteins (1) (2) (3) (4) (5) . A variety of studies suggest that ligand binding involves domains in the NH2-terminal regions of both the integrin a and 3 chains. Within the (3 chain, ligand binding occurs in the vicinity ofamino acids 100-200 (6) (7) (8) , a region that contains sequences highly conserved in nearly all known ( subunits. Within the a chain, ligands bind in the region of [3] [4] putative binding sites for divalent cations, which have the partial EF hand sequence motif DXDXDGXXD (9-1 1). All known integrin ligand binding events have been found to be inhibited by EDTA, consistent with an essential role for a chain cation sites.
On some cells (particularly leukocytes and platelets) integrin-mediated adhesion can be modulated by a process known as "inside out" signaling. Upon triggering ofcells with a variety of agonists, including the phorbol ester PMA, a poorly characterized signal is generated, resulting in substantially increased cell adhesion ( [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] ). Also, monoclonal antibodies to (31 (22) (23) (24) (25) (26) (2 (27) , and (3 (28) integrins have been found, which stimulate integrin-mediated adhesion by a mechanism probably distinct from phorbol ester stimulation (29) .
Within the group of integrins that share the (31 subunit (called VLA proteins), VLA-2 (a2f( I) often functions as an adhesion receptor mediating cell attachment to collagen and laminin (30) (31) (32) (33) (34) (35) . On some cell types, however, it acts strictly as a collagen receptor (33) (34) (35) (36) , and on at least one cell it did not bind to either collagen or laminin (2) . As seen with other integrins, these VLA-2 adhesion functions are inhibited by EDTA, indicating a requirement for divalent cations. Notably, although VLA-2-mediated adhesion to collagen is promoted by Mg++ and Mn++, it is inhibited in the presence ofCa++ (36, 37) . Also, like other integrin functions, VLA-2-mediated cell adhesion can be dramatically stimulated by certain antibodies to the (31 subunit (24) , and to a variable extent by PMA (20, 29 
Methods
Cell lines. K562 erythroleukemia cells were transfected with cDNA encoding the a2 subunit of VLA-2 in the pFneo expression vector to obtain K562-form 0 (binds neither collagen nor laminin) and K562-form C (binds collagen only), or with the pFneo vector alone to obtain KpF. Isolation and characterization of these cell lines (29) and the RDA2 cell line (40) , which adheres to both collagen and laminin, have been described. RD cells transfected with chimeric a cDNA, containing the extracellular domains of a2 and the cytoplasmic domains of a4 (X2C4) or aS (X2C5), have also been described (41) .
Monoclonal antibodies. AA 10 (38), 5E8 (42) , and 12F1 (43) MgCl2 and 4% bovine calf serum. Incubation with gentle rocking proceeded for 30-60 min, after which cells were washed twice in the same buffer, dissolved in 0.5 ml Solvable (New England Nuclear, Boston, MA), and cell-bound radioactivity was determined by scintillation counting.
Cell adhesion assays. Cell attachment to matrix proteins was determined as described (41) . Briefly, cells were suspended in RPMI-5% FCS at 3-5 x 106/ml, treated with 5 Mg/ml (2',7')-bis(carboxyethyl)-(5,6)-carboxyfluorescein (Molecular Probes, Inc., Eugene, OR) at 37°C for 30 min, then washed twice in PBS. After incubation with monoclonal antibodies or buffer containing specific divalent cations, 5
x I0' cells in 0.1 ml were added to plastic tissue culture plates precoated with collagen or laminin. Adhesion was permitted to occur for 20 min at 37°C, unattached cells were removed by gentle washing, and fluorescent cell adherence was determined using a 96-well fluorescence analyzer (IDEXX Co., Portland, ME), and normalized to wells containing 50,000 cells. Background values for cell adhesion to wells coated with 0.1 % BSA were subtracted. All results are expressed as the mean number of cells bound per mm2 of surface area (±SD) for triplicate determinations.
Interaction ofvirus and ECMproteins with isolated VLA-2. Receptor binding to collagen and laminin sepharose was performed as described (29 
Results
Interaction ofvirus and ECMproteins with differentfunctional forms of VLA-2. We have previously shown that a2-transfected RD cells express VLA-2 that binds to both collagen and laminin (41) , and thus is designated VLA-2 form CL. In contrast, a2-transfected K562 erythroleukemia cells (KA2 cells) expressed VLA-2 that adhered to collagen but not laminin (form C), or adhered neither to collagen nor to laminin (form 0) (29) , as shown in Fig. 1 A and B. We previously showed that echovirus 1 bound to VLA-2 form CL on RD cells (38) , and here we show that virus also bound to VLA-2 form C and form 0 on KA2 cells (Fig. 1 C) (Fig. 3 ). The antibody 12F1 had no effect on RDA2 cell adhesion to ECM proteins collagen and laminin (A, B), but completely abrogated virus binding to RDA2 cells (C) and to HeLa and KA2 cells (not shown). Two other antibodies, 5E8 and AA 10, which inhibited cell attachment to collagen and laminin, gave complete inhibition of virus binding (C). Additional anti-VLA-2 antibodies with no effect on ECM attachment (J. Adams (Fig. 5 A) . In contrast, binding of radiola- beled virus was not altered in the presence of TS2/ 16 or the other anti-#l antibodies ( Fig. 5 B) ; AA1O, an anti-a2 mAb, completely inhibited virus binding as seen previously (38) and in Fig. 3 above. Though less dramatic than in Fig. 5 , TS2/ 16 stimulation of RDA2 cell adhesion to collagen was also seen in Fig. 2 , especially at the lower collagen dose (Fig. 2 A) . In Fig. 2 C, as in Fig. 5 B, TS2/ 16 had little effect on virus binding. Cation requirementsfor VLA-2 mediated virus binding and adhesion to ECMproteins. Consistent with previously reported results for platelets (36, 52), VLA-2-mediated attachment of RDA2 cells to collagen was inhibited by EDTA and reconstituted by the addition of 2 mM ofeither Mg++ or Mn + but not Ca++ (Fig. 6 A) . In contrast, substantial virus binding to RDA2 cells was observed either in the absence or presence ofextracellular cations, or in the presence of 2 mM EDTA (Fig. 6 B) Interactions ofsolubilized VLA-2 with virus and with collagen. To determine whether the differences between VLA-2-mediated virus binding and cell adhesion observed in the preceding experiments reflected direct interaction of VLA-2 with ligands or were the end result of more complex cellular processes, we examined the interaction of solubilized VLA-2 with virus and collagen. Previous studies have shown close parallels between VLA-2-mediated cell adhesion and direct interaction of VLA-2 with collagen and laminin. In particular, interaction of solubilized and/or purified VLA-2 with its extracellular matrix ligands is inhibited by EDTA (33, 36, 37) , by Ca++ (36, 37), or by specific monoclonal antibodies (36) . In addition, different functional forms of VLA-2, isolated from specific cell types (33, 34) bind directly to ligands with the same specificity as the cells from which they were derived. As shown in Table II (and in similar experiments described elsewhere [29 ] ), detergent-solubilized VLA-2 from a2-transfected K562 cells bound at only a low to moderate level to collagen-Sepharose at 4°C. However, in the presence of the anti-f1 mAb TS2/ 16, adhesion ofsoluble VLA-2 to collagen was enhanced approximately HeLa or KA2 transfectants using HAS-4-coated protein A Sepharose beads and measured the attachment ofradiolabeled virus to receptor protein (Fig. 7) . Virus bound specifically to beads coated with VLA-2 ( Fig. 7 A) ; no binding was observed to beads coated with isotype-matched control antibodies and exposed to the same cell extracts. In experiments with extracts from iodinated HeLa cells, HAS-4-coated beads bound specifically the a and f subunits of VLA-2 (Fig. 8) .
Virus attachment to isolated VLA-2 was specifically prevented by the anti-a2 monoclonal antibody AA 10, and also by 12F1 (Fig. 7 A) , which prevented virus attachment to cells, but not cell attachment or VLA-2 binding to extracellular matrix proteins ( Fig. 3 and Table II ). Virus bound equally well to VLA-2 isolated from KA2 (form 0) and KA2 (form C) transfectants, but did not bind to HAS-4-coated beads exposed to cell extracts from mock-transfected K562 cells, which do not express VLA-2 (Fig. 7 B) . Finally, as determined for virus attachment to intact cells, virus binding to isolated VLA-2 was not suppressed in the presence of calcium, was not stimulated by manganese, and occurred even in the presence of 2 mM EDTA (Fig. 7 C) .
Post-ligand binding events. Previously generated chimeric forms of the a2 subunit (called X2C4 and X2C5) contained cytoplasmic domains from integrin a4 and aS subunits respectively (39) . When these chimeric a2 molecules and wild type a2 (RDA2 = X2C2) were transfected into RD cells, adhesion to collagen and laminin was essentially indistinguishable, but post-ligand binding events such as cell migration and collagen gel contraction were dramatically altered (39) . When tested for echovirus I binding, RDA2 (X2C2), RD-X2C4, and RD-X2C5 cells all bound virus equally well (Table III) . In a test of susceptibility to infection, all these cell lines were killed within 24 h when infected with virus at either 0.5 or 0.05 PFU per cell; in contrast, mock-transfected RDpF cells, which express little or no VLA-2, showed no evidence of cytopathic effect even after 48 h (Table III) . This experiment indicated that the a2 
Discussion
In this paper and in previous papers, VLA-2-mediated adhesion to ECM ligands has been characterized in terms of celltype specific differences in function, important #Il and a2 subunit epitopes, phorbol ester activation, anti-flI mAb stimulation, EDTA inhibition, and the relative effectiveness of Mg++ compared with Ca". In every one ofthese six aspects, we have found that virus binding to VLA-2 is markedly different from ECM binding. We have measured the interaction ofboth cellular and solubilized VLA-2 with both viral and ECM ligands. Consistent with our own and others' experience, VLA-2-mediated cell adhesion to ECM proteins closely paralleled the binding of VLA-2 to ECM proteins observed in cellfree systems. Similarly, we found that the important characteristics of virus attachment to cells are reproduced in assays using isolated VLA-2. Thus, at the molecular as well as the cellular level, VLA-2 interacts quite differently with virus and ECM ligands. The identification of VLA-2 as a receptor for echovirus 1 was based on the demonstration that anti-a2 monoclonal antibodies block virus binding and infection, and that RD cells deficient in a2 expression gain capacity to bind virus and become infected when transfected with cDNA encoding a2 (38) .
In this report we describe another VLA-2 negative cell line, K562, that binds virus after transfection with a2 cDNA. Furthermore, the demonstration that virus bound directly to VLA-2 isolated on beads provides novel confirmatory evidence for the direct role of this protein in virus attachment.
VLA-2 interactions with virus and ECM proteins occur by quite different mechanisms and can be regulated independently. Whatever structural features permit different functional forms of VLA-2 to bind differentially to ECM proteins, they are not recognized by virus. In every cell analyzed, VLA-2 was constitutively active with respect to virus binding, and addition of PMA or TS2/ 16 caused no further increase in binding. To stimulate cell adhesion to collagen and laminin, phorbol esters probably trigger intracellular signaling and/or cytoskeletal interaction pathways, whereas mAb TS2/ 16 apparently induces a favorable conformational change in the 031 subunit (29) . Regardless of the precise details for these two distinct mechanisms for regulating cell adhesion to ECM proteins, we have found that neither is relevant to virus binding.
Although some anti-O3I antibodies strongly blocked VLA-2-mediated adhesion to ECM, no anti-,Bl antibody has yet shown strong blocking of virus binding. These results suggest that virus may primarily interact with the a2 subunit. Some anti-a2 antibodies were found to block both ECM and virus binding, but it appears that echovirus 1 may utilize additional contact sites, not critical for ECM binding. Experiments in progress are aimed at mapping virus and ligand binding sites to determine their precise locations.
The observation that echovirus binding and subsequent cell infection were not substantially inhibited by EDTA may provide the best evidence that echovirus is a highly atypical ligand for an integrin. In contrast, binding and subsequent cell adhesion triggered by all other known integrin ligands (including ECM, serum and complement proteins, and members of the immunoglobulin superfamily) are completely inhibited in the presence of EDTA. Consistent with the relatively minimal effect of cations on virus binding, Ca++ failed to inhibit virus binding, again in marked contrast to its strong negative effect on VLA-2-mediated adhesion to ECM (36, 37) .
It has been proposed that aspartate residues within ligands bind directly to EF-hand cations within integrins, thus supplying a missing coordination group (7, 53, 54) . This obviously cannot be the case for echovirus binding, which occurs in the absence of divalent cations. Thus, whereas VLA-2 binding to collagen may be through recognition of a KDGEA sequence (55), a defined triple helical region (56), or, perhaps, for some cell types, a sterically constrained RGD-containing sequence (57), we predict that VLA-2 is unlikely to recognize such domains on the surface of echovirus 1.
We found that virus-induced cytopathic effect (and thus virus uptake) was not noticeably influenced by exchange of a2 subunit cytoplasmic domains. In contrast, collagen-mediated cell migration and collagen gel contraction are markedly dependent on particular a2 subunit cytoplasmic domain substitutions (39) . Thus, although detailed mechanisms for virus internalization and cell killing remain to be determined, we hypothesize that these post-ligand binding mechanisms are quite distinct from those involved in cell migration and collagen gel contraction.
Two other picornaviruses, foot-and-mouth disease virus (FMDV) (58) and coxsackievirus A9 (59), may also bind to integrins, although this has not been definitively established.
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Those viruses are believed to bind susceptible cells by means of an RGD-containing peptide, which in the case of FMDV is known to protrude from the virus surface (60) . Given that RGD peptides are prototypical ligands for several integrins and also display strong cation dependence, we predict that FMDV and coxsackievirus A9 will not share the atypical binding properties of echovirus 1. In conclusion, we have found that VLA-2 binding to echovirus 1 is strikingly different from ECM binding in every aspect analyzed, thus underscoring that the same receptor serves markedly different functions for parasite and host. A practical consequence of these results is that eventual therapeutic interventions could be aimed at inhibition of echovirus 1 binding without disturbing normal VLA-2 function.
